Singular Genomics Systems Inc
NASDAQ:OMIC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Singular Genomics Systems Inc
PP&E Net
Singular Genomics Systems Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
PP&E Net
$71.5m
|
CAGR 3-Years
210%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
PP&E Net
$9.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
Danaher Corp
NYSE:DHR
|
PP&E Net
$5.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
PP&E Net
$773.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
PP&E Net
$1.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
PP&E Net
$791m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
15%
|
See Also
What is Singular Genomics Systems Inc's PP&E Net?
PP&E Net
71.5m
USD
Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's PP&E Net amounts to 71.5m USD.
What is Singular Genomics Systems Inc's PP&E Net growth rate?
PP&E Net CAGR 3Y
210%
Over the last year, the PP&E Net growth was 26%. The average annual PP&E Net growth rates for Singular Genomics Systems Inc have been 210% over the past three years .